Intensification With Apalutamide/ADT Improves PSA PFS in Biochemically Recurrent Prostate Cancer

1 year ago 63

Apalutamide/ADT maintains quality of life, demonstrates improved PSA progression-free survival in recurrent prostate cancer according to PRESTO trial.

1. Homepage
2. Prostate Cancer
3. Intensification With Apalutamide/ADT Improves PSA PFS in Biochemically Recurrent Prostate Cancer